Tech Company Financing Transactions

Scenic Biotech Funding Round

Scenic Biotech, based in Amsterdam, raised $31 million from BioMedPartners, Eir Ventures and Vesalius Biocapital.

Transaction Overview

Company Name
Scenic Biotech
Announced On
3/11/2022
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series A
Investors

BioMedPartners (Lead Investor) (Michael Wacker)

Eir Ventures (Lead Investor) (Stephan Christgau)

Vesalius Biocapital (Lead Investor) (Stephane Verdood)

BioGeneration Ventures

INKEF Capital

Oxford Sciences Innovations

Proceeds Purpose
The company intends to use the funds to accelerate the transition into a development stage company, advancing its in-house pipeline and supporting the creation of new programs based on its Cell-Seq genetic modifier target discovery platform including new industry collaborations.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Science Park 106
Amsterdam, 1098 XG
The Netherlands
Phone
Undisclosed
Website
www.scenicbiotech.com
Email Address
[email protected]
Overview
We specialize in evolution inspired medicine for rare diseases. Scenic Biotech is focused on identifying genetic modifiers for drug intervention. Also known as disease suppressors, genetic modifiers are genes that act to suppress or completely block the effect of a disease-causing mutated gene.
Profile
Scenic Biotech LinkedIn Company Profile
Social Media
Scenic Biotech Company Twitter Account
Company News
Scenic Biotech News
Facebook
Scenic Biotech on Facebook
YouTube
Scenic Biotech on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Oscar Izeboud
  Oscar Izeboud LinkedIn Profile  Oscar Izeboud Twitter Account  Oscar Izeboud News  Oscar Izeboud on Facebook
Chief Scientific Officer
Sebastian Nijman
  Sebastian Nijman LinkedIn Profile  Sebastian Nijman Twitter Account  Sebastian Nijman News  Sebastian Nijman on Facebook
VP - General Counsel
Margot Hoppe
  Margot Hoppe LinkedIn Profile  Margot Hoppe Twitter Account  Margot Hoppe News  Margot Hoppe on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/11/2022: Bodyguard.ai venture capital transaction
Next: 3/11/2022: Plinqit venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.